|
RAB14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.057600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.462400E-01 |
| Normal-vs-Stage2 |
2.730400E-01 |
| Normal-vs-Stage3 |
4.838800E-01 |
| Normal-vs-Stage4 |
1.219620E-01 |
| Stage1-vs-Stage2 |
1.401160E-01 |
| Stage1-vs-Stage3 |
2.566600E-01 |
| Stage1-vs-Stage4 |
6.427800E-02 |
| Stage2-vs-Stage3 |
5.415800E-01 |
| Stage2-vs-Stage4 |
8.147400E-01 |
| Stage3-vs-Stage4 |
3.444000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.770000E-01 |
| Normal-vs-AfricanAmerican |
3.051800E-01 |
| Normal-vs-Asian |
9.047600E-01 |
| Caucasian-vs-AfricanAmerican |
2.048000E-01 |
| Caucasian-vs-Asian |
7.376200E-01 |
| AfricanAmerican-vs-Asian |
3.663000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.861400E-01 |
| Normal-vs-Female |
9.692000E-01 |
| Male-vs-Female |
1.988020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.890800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.427600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.857900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.469200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.155800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.071710E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.759630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.886040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.494200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.832800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.179400E-01 |
| Classical-VS-Follicular |
4.05410000000606E-05 |
| Classical-VS-Other |
1.680450E-01 |
| Classical-VS-Normal |
3.226400E-01 |
| Tall-VS-Follicular |
1.287010E-01 |
| Tall-VS-Other |
3.763800E-01 |
| Tall-VS-Normal |
7.168000E-01 |
| Follicular-VS-Other |
9.914200E-01 |
| Follicular-VS-Normal |
1.331880E-02 |
| Other-VS-Normal |
2.106800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.532800E-01 |
| Normal-vs-N1 |
1.754020E-01 |
| N0-vs-N1 |
4.999200E-01 |
|
|
